2018            

 

1. Sathekge M, Knoesen O, Bruchertseifer F, Reyneke F, Kratochwil C, Lengana T, Giesel F, Lawal I, Boshomane G, Vorster M, Morgenstern A. Initial experience with ²²⁵Ac-PSMA-617 in patients with advanced-stage prostate cancer. Journal of Nuclear Medicine. 2018 May 1;59(supplement 1):528-.

 

2. Sathekge M, Bruchertseifer F, Knoesen O, Reyneke F, Lawal I, Lengana T, Davis C, Mahapane J, Corbett C, Vorster M, Morgenstern A. ²²⁵ Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study. European journal of nuclear medicine and molecular imaging. 2018 Sep 19:1-0.

 

3. Ankrah AO, Klein HC, Span LF, de Vries EF, Dierckx RA, Sathekge MM, Glaudemans AW. The role of PET in monitoring therapy in fungal infections. Current pharmaceutical design. 2018 Feb 1;24(7):795-805.

 

4. Ankrah AO, Span LF, Klein HC, de Jong PA, Dierckx RA, Kwee TC, Sathekge MM, Glaudemans AW. Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections. European journal of nuclear medicine and molecular imaging. 2018 Oct 21:1-0.

 

5. Vorster M, Modiselle MR, Corbett CS, Lawal IO, Buscombe JR, Sathekge MM. First results and experience with PRRT in South Africa. World journal of nuclear medicine. 2018 Apr;17(2):86.

 

6. Sathekge M, Lengana T, Maes A, Vorster M, Zeevaart J, Lawal I, Ebenhan T, Van de Wiele C. ⁶⁸ Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans. European journal of nuclear medicine and molecular imaging. 2018 Feb 1;45(2):226-34.

 

7. Lawal I, Louw L, Warwick J, Nyakale N, Steyn R, Lengana T, Ellmann A, Kotze T, Vangu M, Vorster M, Sathekge M. The College of Nuclear Physicians of South Africa Practice Guidelines on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours. South African Journal of Surgery. 2018 Sep;56(3):55-64.

 

8. Lengana T, Lawal IO, Boshomane TG, Popoola GO, Mokoala KM, Moshokoa E, Maes A, Mokgoro NP, Van de Wiele C, Vorster M, Sathekge MM. ⁶⁸Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?. Clinical genitourinary cancer. 2018 Oct 1;16(5):392-401.

 

9. Afaq A, Alahmed S, Chen SH, Lengana T, Haroon A, Payne H, Ahmed H, Punwani S, Sathekge M, Bomanji J. Impact of ⁶⁸Ga-prostate-specific membrane antigen PET/CT on prostate cancer management. Journal of Nuclear Medicine. 2018 Jan 1;59(1):89-92.

 

10. Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. An overview of targeted alpha therapy with ²²⁵Actinium and ²¹³Bismuth. Current radiopharmaceuticals. 2018 Dec 1;11(3):200-8.

 

11. Snyman LC, Bryant EP, Wethmar EI, De Greve T, Reyneke F, Sathekge MM, Lindeque BG, Abu-Rustum NR. Use of a Sentinel Lymph Node Biopsy Algorithm in a South African Population of Patients With Cervical Cancer and High Prevalence of Human Immunodeficiency Virus Infection. International Journal of Gynecological Cancer. 2018 Sep 1;28(7):1432-7.

 

12. Giesel FL, Will L, Lawal I, Lengana T, Kratochwil C, Vorster M, Neels O, Reyneke F, Haberkon U, Kopka K, Sathekge M. Intraindividual Comparison of ¹⁸F-PSMA-1007 and ¹⁸F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study. Journal of Nuclear Medicine. 2018 Jul 1;59(7):1076-80.

 

13. Bracke N, Janssens Y, Wynendaele E, Tack L, Maes A, Van de Wiele C, Sathekge M, De Spiegeleer B. Blood-brain barrier transport kinetics of NOTA-modified proteins: the somatropin case. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2018.

 

14. Kleynhans J, Grobler AF, Ebenhan T, Sathekge M, Zeevaart JR. Radiopharmaceutical enhancement by drug delivery systems: A review. Journal of Controlled Release. 2018 Aug 4.

 

15. Vorster M, Buscombe J, Saad Z, Sathekge M. Past and Future of ⁶⁸Ga-citrate for Infection and Inflammation Imaging. Current pharmaceutical design. 2018 Feb 1;24(7):787-94.

 

16. Ebenhan T, Sathekge MM, Lengana T, Koole M, Gheysens O, Govender T, Zeevaart JR. ⁶⁸Ga-NOTA-Functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry, and First-in-Human PET/CT Imaging of Infections. Journal of Nuclear Medicine. 2018 Feb 1;59(2):334-9.

 

17. Lawal IO, Ankrah AO, Mokoala KM, Popoola GO, Kaoma CA, Maes A, Mokgoro NP, Van de Wiele C, Sathekge MM. Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection. Nuklearmedizin. 2018 Sep;57(05):190-7.

 

18. Lawal IO, Vorster M, Ankrah AO, Sathekge MM. The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progress. European journal of nuclear medicine and molecular imaging. 2018 Jul;45(7):1270-1.

 

 

19. Muranda AZ, Greeff L, Sathekge MM, Lengano T, Karusseit VO. Cryptococcoma of a transplanted kidney in a patient presenting with recurrent urinary tract infection: a case report. BMC nephrology. 2018 Dec;19(1):94.

 

20. Tack L, Bracke N, Verbeke F, Wynendaele E, Pauwels E, Maes A, Van de Wiele C, Sathekge M, De Spiegeleer B. Biological Characterisation of Somatropin-Derived Cryptic Peptides. International Journal of Peptide Research and Therapeutics. 2018:1-3.

 

21. Lawal IO, Ankrah AO, Popoola GO, Lengana T, Sathekge MM. Arterial inflammation in young patients with human immunodeficiency virus infection: A cross-sectional study using F-18 FDG PET/CT. Journal of Nuclear Cardiology. 2018:1-8.

 

22. Lawal IO, Ankrah AO, Popoola GO, Nyakale NE, Boshomane TG, Reyneke F, Lengana T, Vorster M, Sathekge MM. ¹⁸F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma. Nuclear medicine communications. 2018 Nov 1;39(11):1005-12.

 

23. Lengana T, van de Wiele C, Lawal I, Maes A, Ebenhan T, Boshomane T, Zeevaart JR, Ankrah A, Mokgoro N, Vorster M, Sathekge M. ⁶⁸Ga-PSMA-HBED-CC PET/CT imaging in Black versus White South African patients with prostate carcinoma presenting with a low volume, androgen-dependent biochemical recurrence: a prospective study. Nuclear medicine communications. 2018 Feb 1;39(2):179-85.

 

24. Lawal I, Ankrah A, Lengana T, Reyneke F, BOSHOMANE G, Mokoala K, Vorster M, Sathekge M. F-18 FDG PET/CT in the assessment of the association of HIV infection with arterial inflammation in young individuals with low risk factors for cardiovascular diseases. Journal of Nuclear Medicine. 2018 May 1;59(supplement 1):446-.

 

25. Ankrah A, Sathekge M. PET/CT in Immunodeficiency Disorders. InPET/CT in Infection and Inflammation 2018 (pp. 15-27). Springer, Cham.

 

26. Sathekge M, Garcia-Perez O, Paez D, El-Haj N, Kain-Godoy T, Lawal I, Estrada-Lobato E. Molecular imaging in musculoskeletal infections with 99m Tc-UBI 29-41 SPECT/CT. Annals of nuclear medicine. 2018 Jan 1;32(1):54-9.

 

27. Lengana T, Lawal I, Boshomane T, Ololade K, Reyneke F, Kaoma C, Mokgoro N, Vorster M, Sathekge M. Salivary Gland Activity Obscures Mandibular Metastasis of Prostate Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET. Clinical nuclear medicine. 2018 Feb;43(2):106-9.

 

 

2017

1. Sathekge M, Knoesen O, Meckel M, Modiselle M, Vorster M, Marx S. 213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2017;44(6):1099.

 

2. Bracke N, Yao H, Wynendaele E, Verbeke F, Xu X, Gevaert B, Maes A, Van de Wiele C, Sathekge M, De Saeger S, De Spiegeleer B. In vitro functional quality characterization of NOTA-modified somatropins. Analytical Chemistry. 2017 Feb 16;89(5):2764-72.

 

3. Ankrah AO, Glaudemans AW, Klein HC, Dierckx RA, Sathekge M. The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases. Nuclear Medicine and Molecular Imaging. 2017 Jun 1;51(2):127-39.

 

4. Dutta J, Baijnath S, Somboro AM, Nagiah S, Albericio F, Torre BG, Marjanovic, Painter B, Zeevaart JR, Sathekge M, Kruger HG, Chuturgoon A. Synthesis, in vitro evaluation, and 68Ga-radiolabeling of CDP1 toward PET/CT imaging of bacterial infection. Chemical Biology & Drug Design. 2017 Mar 22.

 

5.Pfannkuchen N, Meckel M, Bergmann R, Bachmann M, Bal C, Sathekge M, Mohnike W, Baum RP, Rösch F. Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases. Pharmaceuticals. 2017 May 18;10(2):45.

 

6. Lawal IO, Nyakale NE, Harry LM, Lengana T, Mokgoro NP, Vorster M, Sathekge MM. Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma. Nuclear medicine communications. 2017 Mar 1;38(3):222-7.

 

7. Sathekge M, Lengana T, Modiselle M, Vorster M, Zeevaart J, Maes A, Ebenhan T, Van de Wiele C. 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients. European journal of nuclear medicine and molecular imaging. 2017;44(4):689.

 

8. Bresser PL, Sathekge MM, Makanjee CR, Van Wyk D, Vorster M. A randomized-controlled study of a modified technique to reduce extracardiac activity in myocardial perfusion imaging. Nuclear medicine communications. 2017 Jan 1;38(1):21-8.

 

9. Lawal IO, Ankrah AO, Mokgoro NP, Vorster M, Maes A, Sathekge MM. Diagnostic sensitivity of Tc‐99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga‐68 PSMA PET/CT. The Prostate. 2017 Jun 26.

 

10. Ebenhan T, Schoeman I, Rossouw DD, Grobler A, Marjanovic-Painter B, Wagener J, Kruger HG, Sathekge MM, Zeevaart JR. Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different 68Ge/68Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans. Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging. 2017 Jun;19(3):469-82.

 

11. Lawal I, Lengana T, Ololade K, Boshomane T, Reyneke F, Modiselle M, Vorster M, Sathekge M. 18F-FDG PET/CT in the detection of asymptomatic malignant melanoma recurrence. Nuklearmedizin. 2017.

 

12. Dutta J, Naicker T, Ebenhan T, Kruger HG, Arvidsson PI, Govender T. Synthetic approaches to radiochemical probes for imaging of bacterial infections. European Journal of Medicinal Chemistry. 2017 Mar 29.

 

Chapters in textbooks

Ebenhan T, Sathekge M. Imaging in the Developing World. InImaging Infections 2017 (pp. 239-247). Springer International Publishing.   Ebenhan T, Wagener C, Bambarger LE, Kalinda AS, Zeevaart JR. Radiochemistry. InImaging Infections 2017 (pp. 77-131). Springer International Publishing.

 

2016

Invited Editorial: Letter from the Guest Editor, Prof Machaba Mike Sathekge.Semin Nucl Med. 2016 Sep;46(5):370-2. doi: 10.1053/j.semnuclmed.2016.06.002.

 

INTERNATIONAL ATOMIC ENERGY AGENCY, Nuclear Cardiology: Guidance on the Implementation of SPECT Myocardial Perfusion Imaging, IAEA Human Health Series No. 23 (Rev. 1), IAEA, Vienna (2016).

 

Vorster M, Maes A, van de Wiele C, Sathekge M. Gallium-68 PET: A Powerful Generator-based Alternative to Infection and Inflammation Imaging. InSeminars in Nuclear Medicine 2016 Sep 30 (Vol. 46, No. 5, pp. 436-447). WB Saunders.doi: 10.1053/j.semnuclmed.2016.04.005. Review.

 

Lawal I, Sathekge M. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection. British Medical Bulletin. 2016 Sep 10.

 

Hudyana H, Maes A, Vandenberghe T, Fidlers L, Sathekge M, Nicolai D, Van de Wiele C. Accuracy of bone SPECT/CT for identifying hardware loosening in patients who underwent lumbar fusion with pedicle screws. European journal of nuclear medicine and molecular imaging. 2016 Feb 1;43(2):349-54.

 

Van de Wiele C, Rimbu A, Belhocine T, DE Spiegeleer B, Sathekge M, Maes A. Reversible mycordial perfusion defects in patients not suffering from obstructive epicardial coronary artery disease as assessed by coronary angiography: a review of the literature. The quarterly journal of nuclear medicine and molecular imaging: official publication of the Italian Association of Nuclear Medicine (AIMN)[and] the International Association of Radiopharmacology (IAR),[and] Section of the Society of... 2016 Mar.

 

Meintjes M, Sathekge M, Makanjee CR, Dickson JC, Endozo R, Rheeder P, Bomanji J. Comparison of rubidium-82 myocardial blood flow quantification with coronary calcium score for evaluation of coronary artery stenosis. Nuclear medicine communications. 2016 Feb 1;37(2):197-206.

 

Ankrah AO, van der Werf TS, de Vries EF, Dierckx RA, Sathekge MM, Glaudemans AW. PET/CT imaging of Mycobacterium tuberculosis infection. Clinical and translational imaging. 2016 Apr 1;4(2):131-44.

 

Ankrah AO, Glaudemans AW, Klein HC, Dierckx RA, Sathekge M. The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases. Nuclear Medicine and Molecular Imaging. 2016:1-3.

 

Pfannkuchen N, Meckel M, Sathekge M, Mohnike W, Roesch F. DOTAZOL as novel bone seeking compound for Ga-68 PET diagnosis and Lu-177 endoradiotherapy of bone metastases: From preclinical to first human results. Journal of Nuclear Medicine. 2016 May 1;57(supplement 2):472-

.

Ismaheel L, Lengana T, Vorster M, Sathekge M. 18F-FDG PET/CT in the evaluation of recurrent malignant melanoma. Journal of Nuclear Medicine. 2016 May 1;57(supplement 2):1569-1569.

 

Ankrah AO, Sathekge MM, Dierckx RA, Glaudemans AW. Imaging fungal infections in children. Clinical and translational imaging. 2016 Feb 1;4(1):57-72.

 

Ankrah AO, Glaudemans AW, Sathekge MM, Klein HC. Imaging latent tuberculosis infection with radiolabeled nitroimidazoles. Clinical and translational imaging. 2016 Apr 1;4(2):157-9.

 

Orunmuyi A, Modiselle M, Lengana T, Ebenhan T, Vorster M, Sathekge M. 68Gallium-Arginine-Glycine-Aspartic Acid and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Chondroblastic Osteosarcoma of the Skull. Nuclear Medicine and Molecular Imaging. 2016:1-3.

 

 

2015

Sathekge, Mike, Moshe Modiselle, Mariza Vorster, Neo Mokgoro, Nozipho Nyakale, Brenda Mokaleng, and Thomas Ebenhan. 68Ga-PSMA imaging of metastatic breast cancer. European Journal of Nuclear Medicine and Molecular Imaging: Volume 42, Issue 9 (2015), Page 1482-1483

 

Lawal, Ismaheel, Mariza Vorster, Tebatso Boshomane, Kehinde Ololade, Thomas Ebenhan, and Mike Sathekge. Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT. Clinical nuclear medicine (2015).

 

Satz, S., R. P. Baum, and M. M. Sathekge. Peptide receptor radionuclide therapy and theranostics beyond neuroendocrine tumors and into the next decade. In JOURNAL OF NUCLEAR MEDICINE, vol. 56. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA: SOC NUCLEAR MEDICINE INC, 2015.

 

Sathekge, Mike, Anton Stoltz, and Olivier Gheysens. Rheumatic Fever: A Forgotten but Still Existing Cause of Fever of Unknown Origin Detected on FDG PET/CT. Clinical nuclear medicine 40, no. 3 (2015): 250-252.

 

Mokaleng, B. B., T. Ebenhan, J. D. Venter, S. Ramesh, H. G. Kruger, B. Marjanovic-Painter, J. R. Zeevaart, and M. M. Sathekge. Preclinical characterization of a novel Ga-68-labeled DOTA-depsipeptidebased imaging agent for noninvasive detection of infection and inflammation.In JOURNAL OF NUCLEAR MEDICINE, vol. 56. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA: SOC NUCLEAR MEDICINE INC, 2015.

 

Ebenhan, T., J. D. Venter, G. E. M. Maguire, H. G. Kruger, T. Mkhize, J. Wagener, J. R. Zeevaart, and M. M. Sathekge. Novel radiopharmaceutical and preclinical aspects of Ga-68-UBI: a selective PET tracer for imaging of infection. In JOURNAL OF NUCLEAR MEDICINE, vol. 56. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA: SOC NUCLEAR MEDICINE INC, 2015.

 

Mokaleng, Botshelo B., Thomas Ebenhan, Suhas Ramesh, Thavendran Govender, Hendrik G. Kruger, Raveen Parboosing, Puja P. Hazari et al. Synthesis, 68 Ga-Radiolabeling, and Preliminary In Vivo Assessment of a Depsipeptide-Derived Compound as a Potential PET/CT Infection Imaging Agent. BioMed research international 2015 (2015).

 

Ebenhan, T., L. Sepini, D. Kotze, B. B. Mokaleng, I. Schoeman, M. Vorster, M. M. Sathekge, and J. R. Zeevaart. Radiopharmaceutical implications toward peptide radiolabeling considering longitudinal performance aspects of SnO2-based Ge-68/Ga-68 generators. In JOURNAL OF NUCLEAR MEDICINE, vol. 56. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA: SOC NUCLEAR MEDICINE INC, 2015.

 

Sathekge, Mike, Farhana Ebrahim Suleman, Mark D. Velleman, and Ralf Clauss. Nuclear Medicine Imaging of Sport Injuries of the Wrist, Hand and Fingers. In Nuclear Medicine and Radiologic Imaging in Sports Injuries, pp. 525-548. Springer Berlin Heidelberg, 2015.

 

Mdlophane, A., T. Ebenhan, B. B. Mokaleng, M. M. Sathekge, and J. R. Zeevaart. Radiolabelling of CDP1-NODAGA with Ga-68 (III) chloride as a potential imaging agent for host-dependent and-independent inflammation. In JOURNAL OF NUCLEAR MEDICINE, vol. 56. 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA: SOC NUCLEAR MEDICINE INC, 2015.

 

Bennie, George, Mariza Vorster, John Buscombe, and Mike Sathekge. The Added Value of a Single-photon Emission Computed Tomography-Computed Tomography in Sentinel Lymph Node Mapping in Patients with Breast Cancer and Malignant Melanoma. World journal of nuclear medicine 14, no. 1 (2015): 41.

 

Nyakale, N., Z. Lockhat, and M. M. Sathekge. Nuclear medicine-induced allergic reactions: review article. Current Allergy & Clinical Immunology 28, no. 1 (2015): 10-17.

 

Vorster, Mariza, Moshe Modiselle, Thomas Ebenhan, Carl Wagener, That Sello, Jan Rijn Zeevaart, Evelyn Moshokwa, and Mike Machaba Sathekge. Fluorine-18-Fluoroethylcholine PET/CT in the detection of prostate cancer: A South African experience. Hellenic journal of nuclear medicine 18, no. 1 (2014): 53-59.

 

2014

 

Kruse, Vibeke, Christophe Van De Wiele, M. Borms, A. Maes, Hans Pottel, M. Sathekge, and Veronique Cocquyt. CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence.Nuklearmedizin 53, no. 4 (2014): 131-138.

 

Clauss, Ralf P., Max Zöttl, and Mike Sathekge. Imaging of the Antidepressant Drug Response Using SPECT and PET. In PET and SPECT in Psychiatry, pp. 325-345. Springer Berlin Heidelberg, 2014.

 

Vorster M, Maes A, Van de Wiele C, Sathekge MM. 68Ga-citrate PET/CT in Tuberculosis: A pilot study. Q J Nucl Med Mol Imaging. 2014 Mar 20. [Epub ahead of print] PubMed PMID: 24651268.

 

Sathekge M, Maes A, Van de Wiele C, Dadachova E. Impact of AIDS in Women who have gender determined health issues. Semin Nucl Med. 2014;44(6):489-498.

 

Sathekge, Mike, Christophe Van de Wiele, and Alberto Signore. "Nuclear Medicine Imaging of Tuberculosis and Human Immunodeficiency Virus." Diagnostic Imaging of Infections and Inflammatory Diseases: A Multidisciplinary Approach (2014): 255-272.

 

Vorster, M., Nyakale, N., & Sathekge, M. (2014). Impulsivity Imaging. In PET and SPECT in Psychiatry (pp. 583-620). Springer Berlin Heidelberg.

Kruse V, Van de Wiele C, Borms M, Maes A, Pottel H, Sathekge M, Cocquyt V. CA Measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve. Nuklearmedizin. 2014 Aug 6;53(4):131-8. doi: 10.3413/Nukmed-0634-13-12. PubMedPMID: 25100557.

 

Vorster M, Sathekge MM, Bomanji J. Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT. Curr Opin Pulm Med. 2014 May;20(3):287-93. doi:10.1097/MCP.0000000000000043. PubMed PMID: 24614238.

 

Van De Wiele C, Sathekge M, Maes A. Targeting monocytes and macrophages by means of SPECT and PET. Q J Nucl Med Mol Imaging. 2014 Sep;58(3):269-275. PubMedPMID: 24844256.

 

Sathekge M, McFarren A, Dadachova E. Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond. Nucl Med Commun. 2014 Aug;35(8):792-6. doi: 10.1097/MNM.0000000000000139. PubMed PMID: 24781008; PubMed Central PMCID: PMC4077982.

 

Vorster M, Maes A, Jacobs A, Malefahlo S, Pottel H, Van de Wiele C, Sathekge MM. Evaluating the possible role of 68Ga-citrate PET/CT in the characterization of indeterminate lung lesions. Ann Nucl Med. 2014 Jul;28(6):523-30. doi: 10.1007/s12149-014-0842-9. Epub 2014 Mar 29. PubMed PMID: 24682926.

 

Ebenhan T, Gheysens O, Kruger HG, Zeevaart JR, Sathekge MM. Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging. Biomed Res Int. 2014;2014:867381. Epub 2014 Aug 27. Review. PubMed PMID: 25243191; PubMed Central PMCID: PMC4163393.

 

Ebenhan T, Chadwick N, Sathekge MM, Govender P, Govender T, Kruger HG, Marjanovic-Painter B, Zeevaart JR. Peptide synthesis, characterization and ⁶⁸Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT. Nucl Med Biol. 2014 May-Jun;41(5):390-400. doi: 10.1016/j.nucmedbio.2014.02.001. Epub 2014 Feb 13. PubMed PMID: 24630816.

 

Mokaleng BB, Ebenhan T, Ramesh S, Govender T, Kruger HG, R Parboosing, Hazari PP,  Mishra AK, Marjanovic-Painter B, Zeevaart JR, Sathekge MM. Synthesis, 68Ga-Radiolabeling, and Preliminary In Vivo Assessment of a Depsipeptide-Derived Compound as a Potential PET/CT Infection Imaging Agent. Biomed Res Int. 2014;2014: Epub 2014. Research Article. PubMed PMID:

 

Sathekge M. Differentiation of HIV-associated lymphoma from HIV-reactive adenopathy using quantitative FDG-PET and symmetry. Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):593-5. doi: 10.1007/s00259-014-2701-2. PubMed PMID: 24469259.

 

Zinn, C., Vorster, M., & Sathekge, M. M. Spinal Tuberculosis Evaluated by Means of 18F-FDG PET/CT: Pilot Study. The Open Nuclear Medicine Journal, 2014, 6, 6-11

 

Huic, D., Almeida, P., Oh, G., Pruzzo, R., Kostadinova, I., Vorster, M., ... & Pascual, T. N. (2014, May). The added value of SPECT/CT in sentinel node identification in melanoma patients-A prospective multicenter IAEA study. In Society of Nuclear Medicine Annual Meeting Abstracts (Vol. 55, No. Supplement 1, p. 654).

Ebenhan T, Zeevaart JR, Venter JD, Govender T, Kruger GH, Jarvis NV, Sathekge MM. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med. 2014 Feb;55(2):308-14. doi:10.2967/jnumed.113.128397. Epub 2014 Jan 16. PubMed PMID: 24434293.

Clauss, Ralf P., Max Zöttl, and Mike Sathekge. Imaging of the Antidepressant Drug Response Using SPECT and PET. PET and SPECT in Psychiatry. Springer Berlin Heidelberg, 2014. 325-345.

 

2013

 

Sathekge, M. Targeted radionuclide therapy. Continuing Medical Education. 2013:31.(8): 289-294. 

 

Vorster M, Maes A, Van deWiele C, Sathekge M. Gallium-68: a systematic review of its nononcological applications. Nucl Med Commun. 2013 Sep;34(9):834-54. 

 

Hatutale A, Vorster M, Ankrah AO, Rheeder P, Sathekge MM. Association of hemodynamic response during dipyridamole stress testing with (99m)Tc-MIBI SPET myocardial perfusion image findings. Hell J Nucl Med. 2013 Oct 2. doi:pii:s002449910096. [Epub ahead of print] 

 

Sathekge M, Wagener J, Smith SV, Soni N, Marjanovic-Painter B, Zinn C, Van de Wiele C, D'Asseler Y, Perkins G, Zeevaart JR. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography. Nuklearmedizin. 2013 Oct 10;52(6). [Epub ahead of print].

 

Iagaru A, Mosci C, Dick DW, Sathekge M, Lapa P, de Lima JM, Gambhir SS.Combined (18)F-fluoride and (18)F-FDG PET/CT: a response based on actual data from prospective studies. Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1922-4. 

 

Mees G, Sathekge M, Maes A, Yves D'Asseler EY, Wiele CV. Radiolabelled probes targeting tumor hypoxia for personalized medicine. Curr Pharm Des. 2013 Sep 11.[Epub ahead of print] Bunschoten A, Welling M, Termaat F, Sathekge M, van Leeuwen FW.

Development and prospects of dedicated tracers for the (molecular) imaging of bacterial infections. Bioconjug Chem. 2013 Nov 7. [Epub ahead of print]  Iagaru A, Mittra E, Mosci C, Dick DW, Sathekge M, Prakash V, Iyer V, Lapa P,Isidoro J, de Lima JM, Gambhir SS.

Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial. J Nucl Med. 2013 Feb;54(2):176-83. Perkins AC, Mshelia DS, Symonds ME,

Sathekge M. Prevalence and pattern ofbrown adipose tissue distribution of 18F-FDG in patients undergoing PET-CT in a subtropical climatic zone. Nucl Med Commun. 2013 Feb;34(2):168-74.

 

Van de Wiele C, Kruse V, Smeets P, Sathekge M, Maes A. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours. Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):290-301.  

 

Sathekge M, Maes A, Van de Wiele C. FDG-PET imaging in HIV infection and tuberculosis. Semin Nucl Med. 2013 Sep;43(5):349-66.

 

2012

 

Masekela R, Gongxeka H, Green RJ, Sathekge M. Positron emission tomography in the prediction of inflammation in children with human immunodeficiency virus related bronchiectasis. Hell J Nucl Med. 2012 Jan-Apr;15(1):23-7.

 

Alexanderson, Better, N. Bouyoucef, S.-E. Dondi, M. Dorbala, S. El-Haj, N. Giubbini, R. Spedali Civili di Brescia, Italy Keng, F Kumar, A. Marcassa, C. Massardo, T. Universidad de Chile, Chile Milan, E Mut, F Obaldo, J., Philippines Paez, D. Peix, A. Thomas, G Vitola, J. Vorster, M. Nuclear Cardiology: Guidance and Recommendations for Implementation in Developing Countries IAEA Human Health Series 23 Subject Classification 0100-Life Sciences. IAEA. STI/PUB/1566 (ISBN: 978-92-0-131710-0). ISSN 2075-3772

Ankrah A, Buscombe J, Sathekge MM. Association between plasma homocysteine and
myocardial SPECT abnormalities in patients referred for suspected myocardial ischaemia. Cardiovasc J Afr. 2012 Jul;23(6):313-7.

Nyakale NE, Clauss RP, Nel HW, Sathekge MM. Blood-brain barrier integrity in a zolpidem-responder patient. S Afr Med J. 2012 Jul 31;102(10):790-1.

 
Better N, Karthikeyan G, Vitola J, Fatima A, Peix A, Novak MD, Soares J Jr,
Bien VD, Briones PO, Vangu M, Soni N, Nguyen A, Dondi M. Performance of rest myocardial perfusion imaging in the management of acute chest pain in the emergency room in developing nations (PREMIER trial). J Nucl Cardiol. 2012 Dec;19(6):1146-53.

Madiba TE, Awotedu AA, du Plessis D, Nchabeleng M, Sathekge MM, Velaphi SC,The Hamilton Naki Clinical Scholarship, 2007 - 2011. SAMJ 2012; 102: 20.

Mshelia DS, Hatutale AN, Mokgoro NP, Nchabaleng ME, Buscombe JR, Sathekge MM. Correlation between serum calcium levels and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy in primary hyperparathyroidism. Clin Physiol Funct Imaging. 2012 Jan;32(1):19-24. 
 
Sathekge M, Maes A, D'Asseler Y, Vorster M, Van de Wiele C. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals. Nucl Med Commun. 2012 Jun;33(6):581-90.

Sathekge M, Maes A, D'Asseler Y, Vorster M, Gongxeka H, Van de Wiele C. Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease. Eur J Nucl Med Mol Imaging. 2012 Apr 18. 
 
Sathekge M, Maes A, Van de Wiele C. Reply: Letter to the Editor. J Nucl Med. 2012; 53:165-166.
 
Zeevaart JR, Szucs Z, Pulker T, Sello T, Bracher J, Sathekge M. Biodistribution and Pharmacokinetics of I-131 Labelled 4-Iodophenylacetic Acid. Curr Radiopharm. 2012; 5: 356-362.

2011

M Sathekge, Maes A, Kgomo M, Stoltz A, Van de Wiele C. Use of 18F-FDG PET to Predict Response to First-Line Tuberculostatics in HIV-Associated Tuberculosis. J Nucl Med. 2011 Jun;52(6):880-5.
 

 Z Szucs M Sathekge; J Wagener, C Wagener, JR Zeevart. SYNTHESIS OF I-131 LABELLED 4-IODOPHENYLACETIC ACID. Journal of Labelled Compounds and Radiopharmaceuticals 2011; 54 (1): 54-58.

M Vorster, M Sathekge. Detection of extensive metastases from anaplastic thyroid cancer by F-18 FDG PET/CT. The Open Nuclear Medicine Journal 2011. 3.


M Sathekge , Buscombe JR. Can positron emission tomography work in the African tuberculosis epidemic? Nucl Med Commun. 2011 Apr;32(4):241-4.


JM Warwick, M Sathekge. PET/CT scanning with a high HIV/AIDS prevalence. Transfus Apher Sci. 2011 Apr;44(2):167-72.

 

A. M. Katua, A. O. Ankrah, M. Vorster, A. van Gelder1, M. M. Sathekge. Optimization of Ordered Subset Expectation Maximization Reconstruction for Reducing Urinary Bladder Artifacts in Single-photon Emission Computed Tomography Imaging.W J Nucl Med 2011; 10: 3-8.

 
Chiacchio S, Mazzarri S, Lorenzoni A, Nyakale N, Boni G, Borsò E, Alsharif A, Grosso M, Manca G, Greco C, Volterrani D, Mariani G. Radionuclide therapy and integrated protocols for bone metastases. Q J Nucl Med Mol Imaging. 2011 Aug;55(4):431-47. Review. PubMed PMID: 21738116.

2010

 

M Vorster, M Sathekge, P Rheeder. Erythromycin as an alternative to reduce interfering extra-           cardiac activity in Myocardial Perfusion Imaging. CardioVascular Journal of Africa 2010 21(3); 142-147.

 

M Sathekge, Maes A, Kgomo M, Van de Wiele C. Fluorodeoxyglucose uptake bylymph nodes of HIV patients is inversely related to CD4 cell count. Nucl MedCommun. 2010 Feb;31(2):137-40

M Sathekge, Maes A, Kgomo M, Stoltz A, Pottel H, Van de Wiele C. Impact of FDG PET on the management of TBC treatment. A pilot study. Nuklearmedizin.2010;49(1):35-40.

M Sathekge, Maes A, Kgomo M, Stolz A, Ankrah A, Van de Wiele C. Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infectedpatients with and without lipodystrophy using FDG-PET. Nucl Med Commun. 2010; 31: 311-314 Feb 6.

M Sathekge, Maes A, Kgomo M, Stoltz A, Pottel H, Van de Wiele C . Dual time-point FDG PET-CT cannot differentiate benign from malignant solitary pulmonary nodules in a TB endemic area. SAMJ 2010; 100(9); 598-601.

M Sathekge, A Maes, H Pottel, A Soltz, C van de Wiele. FDG uptakein lymph nodes of HIV and TB patients: Implications for staging.  Quarterly Nucl Med 2010; 54 (6): 698-703.

M Sathekge. FDG PET imaging in Gynaecology. Guest Editorial. O&G Forum 2010; 20: 37-39.

Sathekge M, Ellmann A. WFNMB: Benchmarking Quality. Editorial. WJNM 2010 September; 9, Supplement 1, S1

N. Nyakale, R Clauss, W Nel, M Sathekge. Clinical and Brain SPECT scan response to zolpidem in patients after brain damage. Arzneimittelforschung. 2010;60(4):177-81.
M Sathekge, Maes A, Al-Nahhas A, Rubello D, Chiti A. What impact can fluorine-18 fluorodeoxyglucose PET/computed tomography have on HIV/AIDS and tuberculosis pandemic?. Editorial. Nucl Med Commun. 2009;30:255-7


M Sathekge, Goethals I, Maes A, van de Wiele C. Positron emission tomography in patients suffering from HIV-1 infection. Eur J Nucl Med Mol Imaging. 2009; 36: 1176-1184.

M M Sathekge. The potential of 68-Ga-labelled peptides in PET imaging of infection. Editorial. Nucl Med Comm 2008: 29; 663-5.

M M Sathekge, J Warwick, MD Vangu, A Ellmann, M Mann. A case for provision of Positron Emission Tomography in South African Public Hospital. SAMJ; 96 2006:598 - 601

T Nunan, M M Sathekge, Pioneering of Positron Emission Tomography in South Africa. Editorial. Nucl Med Comm 2007 28; 235-7.

M M Sathekge, NP Mokgoro, P Mpikashe, OE Ramafi. I-123 Uptake by intrathoracic stomach.   
Clin Nucl Med 2005: 30(1);42.

F Naude, W v Vuuren, K Venter, V pellegrin, JL Holl, M M Sathekge. Impact of scintimammography in breast cancer. SAJR; March 2006.

NE Nyakale, M Vorster, P Mpikashe, W v Vuuren, BJ Meyer, M M Sathekge. “Thymoma detection with Tc-99m MIBI SPECT/CT” Case of the Month. Applied Radiology as a Radiological In Press.

W v Vuuren, NE Nyakale, F Naude , BJ Meyer, M M Sathekge. Pheochromocytoma and Parganglioma. Two Cases. SA FAM Pract 2007; 29(5): 42-5

M Al-Makhzomi , M M Sathekge , P Seynaeve, D Nicolaij, Maes A. PET/CT positive brown tumour - a potentially misleading finding in the evaluation of a patient for malignant primary tumor or metastases. SAJR; Nov 2007

F Ismail, Z Lockhat, M Sathekge, N Khan, I van de Werke, N Adroos, D Reynders, M Kruger. Metastatic calcification as a result of extensive bone metastases in a paediatric patient with Parameningeal Embryonal Rhabdomyosarcoma. South African Journal of Radiology 2008; 12(1): 10-12.

P Mpikashe, M M Sathekge, B J Meyer. Protein-losing enteropathy demonstrated on Tc-99m HAS. South African Journal of Radiology 2008; 12(2): 36-37.